PTO- 1478 |
Approved for use through 07/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90830955 |
Filing Date: 07/15/2021 |
Input Field |
Entered |
SERIAL NUMBER | 90830955 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\908\309\90830955\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | CONSIDER |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) blue and maroon is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of the word CONSIDER in lowercase letters, but for the letter "D," which is written with a capital letter, and where the letters "SID" are maroon and the remaining letters are blue, followed by a maroon chevron design to the right. |
PIXEL COUNT ACCEPTABLE | NO |
PIXEL COUNT | 627 x 85 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | CSL Behring AG |
*MAILING ADDRESS | Wankdorfstrasse 10 |
*CITY | Bern |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Switzerland |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
CH-3000 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | aktiengesellschaft |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED | Switzerland |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 041 |
*IDENTIFICATION | Educational services in the field of health and treatment; Publication of the results of clinical trials. |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials. |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 044 |
*IDENTIFICATION | Providing medical information and treatment information in the field of health, pharmaceuticals and clinical trials. |
FILING BASIS | SECTION 1(b) |
ATTORNEY INFORMATION | |
NAME | Scott D. Woldow |
ATTORNEY DOCKET NUMBER | 034845.290 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Smith, Gambrell & Russell LLP |
INTERNAL ADDRESS | Suite 400 |
STREET | 1055 Thomas Jefferson Street, NW |
CITY | Washington |
STATE | District of Columbia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 20007 |
PHONE | 202-973-2612 |
FAX | 202-263-4312 |
EMAIL ADDRESS | swoldow@sgrlaw.com |
OTHER APPOINTED ATTORNEY | Anca M. Marcu |
CORRESPONDENCE INFORMATION | |
NAME | Scott D. Woldow |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | swoldow@sgrlaw.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | amarcu@sgrlaw.com; docketing@sgrlaw.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 3 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 1050 |
*TOTAL FEES PAID | 1050 |
SIGNATURE INFORMATION | |
SIGNATURE | /Anca Marcu/ |
SIGNATORY'S NAME | Anca M. Marcu |
SIGNATORY'S POSITION | Associate Attorney, Smith Gambrell & Russell LLP, Pennsylvania Bar Member |
SIGNATORY'S PHONE NUMBER | 202-263-4306 |
DATE SIGNED | 07/15/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 07/31/2021. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 90830955 |
Filing Date: 07/15/2021 |
The applicant's current Correspondence Information: |
Scott D. Woldow |
PRIMARY EMAIL FOR CORRESPONDENCE: swoldow@sgrlaw.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): amarcu@sgrlaw.com; docketing@sgrlaw.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|